Andrew S. Levey | Academic Influence

Andrew S. Levey's AcademicInfluence.com Rankings

Andrew S. Levey

Engineering

#1278

World Rank

#1918

Historical Rank

#502

USA Rank

Electrical Engineering

#163

World Rank

#190

Historical Rank

#75

USA Rank

engineering Degrees

Andrew S. Levey

Computer Science

#2258

World Rank

#2352

Historical Rank

#1015

USA Rank

Computational Linguistics

#25

World Rank

#25

Historical Rank

#8

USA Rank

Machine Learning

#120

World Rank

#121

Historical Rank

#40

USA Rank

Database

#219

World Rank

#227

Historical Rank

#107

USA Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

Andrew S. Levey's Degrees

PhD Computer Science Stanford University

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2025

Why Is Andrew S. Levey Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Andrew S. Levey is an American nephrologist who transformed chronic kidney disease clinical practice, research, and public health by developing equations to estimate glomerular filtration rate , and leading the global standardization of CKD definition and staging.

(See a Problem?)

Andrew S. Levey's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A new equation to estimate glomerular filtration rate. (2009) (18088)
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation (1999) (14928)
K/DOQI clinical practice guidelines for chronic kidney disease (2002) (8858)
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate (2006) (4931)
Prevalence of chronic kidney disease in the United States. (2007) (4666)
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification (2003) (4539)
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. (2003) (4087)
Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury (2012) (4027)
Chronic kidney disease (2012) (3913)
Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease (2013) (3866)
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). (2005) (3290)
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis (2010) (3137)
Estimating glomerular filtration rate from serum creatinine and cystatin C. (2012) (2845)
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. (2003) (2815)
Assessing kidney function--measured and estimated glomerular filtration rate. (2006) (2731)
A simplified equation to predict glomerular filtration rate from serum creatinine (2000) (2030)
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease (1994) (2009)
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (2011) (1911)
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020) (1788)
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. (2003) (1718)
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. (2007) (1683)
Serum creatinine as an index of renal function: new insights into old concepts. (1992) (1620)
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. (2006) (1453)
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. (2004) (1204)
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. (2006) (1160)
Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis (2003) (1137)
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. (2009) (1106)
Effect of dialysis dose and membrane flux in maintenance hemodialysis. (2002) (1073)
K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease (2004) (1050)
Evolving importance of kidney disease: from subspecialty to global health burden (2013) (909)
A predictive model for progression of chronic kidney disease to kidney failure. (2011) (900)
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. (2003) (864)
Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate (Annals of Internal Medicine (2006) 145, (247-254)) (2008) (848)
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011) (841)
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011) (841)
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. (2012) (831)
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? (2009) (791)
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. (2008) (777)
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. (2000) (770)
Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. (2010) (757)
Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. (2014) (745)
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. (2001) (725)
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. (2002) (703)
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. (2011) (690)
The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. (1994) (689)
Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease (2001) (679)
Cystatin C versus creatinine in determining risk based on kidney function. (2013) (670)
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. (2011) (645)
"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. (1998) (641)
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. (2003) (640)
Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. (2002) (631)
Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). (2001) (610)
Factors other than glomerular filtration rate affect serum cystatin C levels. (2009) (604)
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy (2017) (580)
Measurement of renal function in chronic renal disease. (1990) (578)
Cardiovascular disease and chronic renal disease: a new paradigm. (2000) (574)
Evaluation of the modification of diet in renal disease study equation in a large diverse population. (2007) (552)
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. (2010) (544)
Measured GFR as a confirmatory test for estimated GFR. (2009) (537)
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. (2001) (529)
Serum creatinine and renal function. (1988) (522)
The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study (2005) (507)
The Effect of Dietary Protein Restriction on the Progression of Diabetic and Nondiabetic Renal Diseases (1996) (506)
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. (2021) (505)
Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. (2004) (496)
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). (2003) (495)
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. (2003) (484)
The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality (2002) (464)
Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. (2002) (449)
Estimating Equations for Glomerular Filtration Rate in the Era of Creatinine Standardization (2012) (442)
Association between body mass index and CKD in apparently healthy men. (2005) (438)
GFR estimation: from physiology to public health. (2014) (430)
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. (2010) (421)
Uric acid and incident kidney disease in the community. (2008) (414)
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. (2006) (400)
Transmission of hepatitis C virus by organ transplantation. (1991) (399)
Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. (1997) (399)
Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. (2015) (397)
Uric acid and long-term outcomes in CKD. (2009) (393)
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. (2001) (389)
Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. (2011) (389)
Hepatitis C virus infection in dialysis and renal transplantation. (1997) (388)
GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. (2014) (388)
C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. (2005) (379)
Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. (1999) (357)
Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis (2013) (350)
Testing for chronic kidney disease: a position statement from the National Kidney Foundation. (2007) (330)
Comparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease (2005) (327)
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors (2017) (324)
The Framingham predictive instrument in chronic kidney disease. (2007) (319)
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations (2004) (318)
Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. (1996) (311)
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. (2020) (309)
Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. (2000) (308)
Prediction equations to estimate glomerular filtration rate: an update (2001) (298)
Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. (2004) (290)
Patient awareness of chronic kidney disease: trends and predictors. (2008) (286)
The kidney and homocysteine metabolism. (2001) (285)
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. (2016) (283)
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. (2007) (283)
Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. (2005) (282)
Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. (2006) (277)
Measurement of kidney function. (2005) (275)
Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. (2009) (269)
Adiponectin and mortality in patients with chronic kidney disease. (2006) (268)
Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. (2009) (262)
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. (2003) (254)
Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease1 (1998) (253)
Resistance Training To Counteract the Catabolism of a Low-Protein Diet in Patients with Chronic Renal Insufficiency (2001) (251)
Demographics and trends in overweight and obesity in patients at time of kidney transplantation. (2003) (247)
Cardiovascular disease risk factors in chronic renal insufficiency. (2002) (243)
Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. (1992) (241)
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. (2008) (239)
Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. (1997) (235)
Cardiovascular disease and subsequent kidney disease. (2007) (234)
Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. (1998) (227)
A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF) (2019) (226)
THE IMPACT OF PRETRANSPLANTATION HEPATITIS C INFECTION ON THE OUTCOME OF RENAL TRANSPLANTATION (1995) (222)
Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. (2004) (221)
DASH (Dietary Approaches to Stop Hypertension) Diet and Risk of Subsequent Kidney Disease. (2016) (219)
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency. (2019) (218)
Erratum: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification (Annals of Internal Medicine (2003) 139 (137-147)) (2003) (217)
Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. (1997) (215)
Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. (1989) (214)
Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival. (2004) (213)
Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. (2005) (206)
Glomerular filtration rate measurements in clinical trials (1993) (205)
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. (2016) (205)
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. (2009) (202)
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. (2007) (201)
Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease (2007) (197)
Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. (2011) (193)
Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? (1998) (193)
A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury. (2015) (184)
Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. (2009) (183)
Effect of intra-dialytic, low-intensity strength training on functional capacity in adult haemodialysis patients: a randomized pilot trial. (2010) (182)
Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. (2003) (182)
Ethnic subgroup differences in hypertension in Pakistan (2003) (180)
Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration. (2011) (171)
Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors (2017) (170)
Global Cardiovascular and Renal Outcomes of Reduced GFR. (2017) (167)
Late initiation of dialysis among women and ethnic minorities in the United States. (2000) (163)
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. (2019) (162)
Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). (2008) (161)
Dietary protein and renal function. (1993) (161)
Conceptual model of CKD: applications and implications. (2009) (160)
Children in South Asia Have Higher Body Mass–Adjusted Blood Pressure Levels Than White Children in the United States: A Comparative Study (2005) (158)
Cystatin C identifies chronic kidney disease patients at higher risk for complications. (2011) (158)
Cardiovascular disease in chronic renal disease. (1999) (157)
Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. (2010) (155)
Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. (2002) (154)
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. (2019) (152)
Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial (2011) (152)
Occult intracranial aneurysms in polycystic kidney disease. When is cerebral arteriography indicated? (1983) (151)
Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. (2009) (151)
Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation. (2011) (151)
Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. (2006) (151)
Choices for Healthy Outcomes In Caring for End Stage Renal Disease (1996) (151)
Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. (2008) (149)
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial (2020) (148)
Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. (1993) (147)
A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease (2017) (146)
Acute Kidney Injury (2017) (145)
Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. (2004) (144)
A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population. (2016) (144)
Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. (2002) (144)
Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. (2005) (143)
Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. (2011) (143)
Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation. (2005) (142)
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. (2008) (142)
Risk Prediction Models for Patients With Chronic Kidney Disease (2013) (141)
Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and Whites (1997) (141)
The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. (2003) (140)
Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms. (2008) (139)
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. (2007) (135)
Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide. (1992) (134)
Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population. (1999) (133)
Serum creatinine as marker of kidney function in South Asians: a study of reduced GFR in adults in Pakistan. (2005) (129)
Surrogate end points for clinical trials of kidney disease progression. (2006) (128)
Design and statistical issues of the hemodialysis (HEMO) study. (2000) (128)
Chronic kidney disease in the elderly--how to assess risk. (2005) (127)
Development and validation of GFR-estimating equations using diabetes, transplant and weight. (2010) (126)
Method of glomerular filtration rate estimation affects prediction of mortality risk. (2009) (126)
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. (2011) (125)
Comparing GFR Estimating Equations Using Cystatin C and Creatinine in Elderly Individuals. (2015) (124)
A controlled study of hepatitis C transmission by organ transplantation (1995) (123)
High urine volume and low urine osmolality are risk factors for faster progression of renal disease. (2003) (122)
Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. (2005) (121)
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. (2005) (118)
Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. (2010) (118)
Kidney Disease, Race, and GFR Estimation. (2020) (116)
Clinical Implications of Estimating Equations for Glomerular Filtration Rate (2004) (116)
Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study. (2008) (114)
Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium (2019) (114)
Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration. (2002) (111)
Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. (1991) (110)
Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patients. (2007) (109)
Kidney Function and Risk of Cardiovascular Disease and Mortality in Kidney Transplant Recipients: The FAVORIT Trial (2012) (109)
Measured and estimated glomerular filtration rate: current status and future directions (2019) (109)
GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD. (2016) (108)
Chronic kidney disease: common, harmful and treatable--World Kidney Day 2007. (2007) (108)
Comorbidity and its change predict survival in incident dialysis patients. (2003) (108)
Nondiabetic Kidney Disease (2002) (107)
GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials. (2014) (107)
Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis. (2014) (107)
Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. (2004) (106)
Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. (2018) (106)
Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients. (2014) (104)
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. (1999) (104)
GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials. (2019) (103)
The Hemodialysis (HEMO) Study: Rationale for Selection of Interventions (1996) (102)
Comorbidity Assessment in Hemodialysis and Peritoneal Dialysis Using the Index of Coexistent Disease (2000) (101)
Estimating the glomerular filtration rate (2001) (101)
GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials. (2014) (99)
Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality. (2017) (98)
The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution. (2013) (98)
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. (2013) (97)
A framework and key research questions in AKI diagnosis and staging in different environments. (2008) (97)
High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients. (2005) (95)
Chronic Kidney Disease in Older People. (2015) (95)
Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. (2006) (92)
Kidney transplantation from unrelated living donors. Time to reclaim a discarded opportunity. (1986) (91)
Mediation analysis of aortic stiffness and renal microvascular function. (2015) (91)
General Practitioners’ Approach to Hypertension in Urban Pakistan: Disturbing Trends in Practice (2005) (90)
Clinical Practice Guidelines in Nephrology: Evaluation, Classification, and Stratification of Chronic Kidney Disease (2005) (90)
Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers. (2004) (90)
The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease. (2005) (89)
Estimated GFR, albuminuria, and complications of chronic kidney disease. (2011) (89)
Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR. (2012) (88)
Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. (2008) (88)
Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. (2007) (87)
US nephrologists' recommendation of dialysis modality: results of a national survey. (2000) (86)
Ethnic differences and determinants of diabetes and central obesity among South Asians of Pakistan (2004) (86)
Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. (2002) (86)
Effects of dietary protein restriction on the progression of moderate renal disease in the modification of diet in renal disease study: Modification of Diet in Renal Disease Study Group (1996) (85)
Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test. (2014) (84)
Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease. (1998) (82)
THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Traditional Cardiac Risk Factors in Individuals with Chronic Kidney Disease (2003) (81)
Filtration markers may have prognostic value independent of glomerular filtration rate. (2012) (80)
Epidemiology of Cardiac Disease in Dialysis Patients (1999) (80)
Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement. (1997) (80)
The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. (2004) (79)
Key comorbid conditions that are predictive of survival among hemodialysis patients. (2009) (79)
Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis. (2002) (76)
Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population. (2007) (76)
Performance of Creatinine and Cystatin C GFR Estimating Equations in an HIV-Positive Population on Antiretrovirals (2012) (76)
Cohort profile: the chronic kidney disease prognosis consortium. (2013) (75)
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease (2019) (73)
Current status and future perspectives for CKD testing. (2009) (72)
Estimating residual kidney function in dialysis patients without urine collection. (2016) (72)
Long-term outcomes in nondiabetic chronic kidney disease. (2008) (72)
Past Decline Versus Current eGFR and Subsequent ESRD Risk. (2016) (72)
CKD: common, harmful, and treatable--World Kidney Day 2007. (2007) (72)
Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT). (2011) (72)
Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data. (2019) (71)
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis. (2016) (70)
Effect of biocompatibility of hemodialysis membranes on mortality in acute renal failure: a meta-analysis. (2002) (70)
Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study. (1996) (69)
Relative risks of Chronic Kidney Disease for mortality and End Stage Renal Disease across races is similar (2014) (69)
GFR as the "Gold Standard": Estimated, Measured, and True. (2016) (69)
Estimation of GFR in South Asians: a study from the general population in Pakistan. (2014) (69)
Body mass index and mortality in CKD. (2007) (68)
Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. (2005) (68)
A Dynamic Predictive Model for Progression of CKD. (2017) (67)
Definition and classification of kidney diseases. (2013) (67)
A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. (2008) (66)
Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults. (2013) (66)
Relationship Between Homocysteine and Mortality in Chronic Kidney Disease (2006) (65)
Traditional cardiac risk factors in individuals with chronic kidney disease. (2003) (65)
Advances in glomerular filtration rate-estimating equations (2010) (65)
U.S. NEPHROLOGISTS’ ATTITUDES TOWARDS RENAL TRANSPLANTATION: RESULTS FROM A NATIONAL SURVEY (2001) (65)
Long-term medical risks to the living kidney donor (2015) (65)
Use of Focus Groups to Identify Concerns about Dialysis (1999) (65)
Urinary sodium excretion and kidney failure in non-diabetic chronic kidney disease (2014) (64)
Relationship of dietary phosphate intake with risk of end stage renal disease and mortality in chronic kidney disease stage 3-5: A Modification of Diet in Renal Disease study (2015) (64)
Automatic reporting of estimated glomerular filtration rate--just what the doctor ordered. (2006) (64)
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). (2009) (63)
Use of glomerular filtration rate measurements to assess the progression of renal disease. (1989) (63)
BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial. (2014) (62)
In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. (1992) (62)
Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial. (2006) (62)
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD. (2016) (61)
Frequency of patient-physician contact and patient outcomes in hemodialysis care. (2004) (61)
Kidney disease, Framingham risk scores, and cardiac and mortality outcomes. (2007) (60)
Clinical practice. Nondiabetic kidney disease. (2002) (59)
Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT). (2014) (59)
Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study. (2016) (59)
Serum fibroblast growth factor-23 is associated with incident kidney disease. (2015) (59)
Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation study. (2014) (59)
Con: Should we abandon the use of the MDRD equation in favour of the CKD-EPI equation? (2013) (58)
Chronic kidney disease, diabetes, and hypertension: what's in a name? (2010) (58)
In Search of a Better Equation - Performance and Equity in Estimates of Kidney Function. (2021) (58)
Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the modification of diet in renal disease study: Modification of diet in renal disease study group (1996) (58)
Urine Potassium Excretion, Kidney Failure, and Mortality in CKD. (2017) (57)
Within-person variability in kidney measures. (2013) (57)
CKD in the elderly--old questions and new challenges: World Kidney Day 2008. (2008) (57)
Risk of End-Stage Renal Disease and Death After Cardiovascular Events in Chronic Kidney Disease (2014) (56)
Incidence and Prognosis of Acute Kidney Diseases and Disorders Using an Integrated Approach to Laboratory Measurements in a Universal Health Care System (2019) (56)
Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study. (2008) (56)
Epidemiology, Diagnosis, and Management of Cardiac Disease in Chronic Renal Disease (2000) (56)
Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population. (2013) (54)
Hepatitis C virus genotype does not affect patient survival among renal transplant candidates (1999) (54)
Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. (1997) (54)
Bias in assessment of health-related quality of life in a hemodialysis population: a comparison of self-administered and interviewer-administered surveys in the HEMO study. (2003) (53)
Chronic kidney disease is common: what do we do next? (2007) (53)
Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. New England Organ Bank Hepatitis C Study Group. (1998) (52)
Assessment of Renal Function (2010) (51)
Inflammation and cardiovascular events in individuals with and without chronic kidney disease. (2008) (51)
Major clinical trials of hypertension: what should be done next? (2005) (50)
Performance of GFR Slope as a Surrogate Endpoint for Kidney Disease Progression in Clinical Trials: A Statistical Simulation. (2019) (50)
Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. (2009) (49)
Effect of dietary protein intake on serum total CO2 concentration in chronic kidney disease: Modification of Diet in Renal Disease study findings. (2005) (49)
How strong are patients' preferences in choices between dialysis modalities and doses? (2004) (49)
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial (2021) (48)
Hyperhomocysteinemia in Renal Transplant Recipients (2002) (48)
The role of systemic hypertension in the progression of nondiabetic renal disease. (2000) (48)
Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. (2007) (48)
Estimation of Glomerular Filtration Rate With vs Without Including Patient Race. (2020) (47)
Estimated Glomerular Filtration Rate From a Panel of Filtration Markers-Hope for Increased Accuracy Beyond Measured Glomerular Filtration Rate? (2018) (47)
Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial. (2017) (46)
Candidate Surrogate End Points for ESRD after AKI. (2016) (46)
Spontaneous changes in the rate of decline in reciprocal serum creatinine: errors in predicting the progression of renal disease from extrapolation of the slope. (1992) (46)
Idiopathic nephrotic syndrome. Puncturing the biopsy myth. (1987) (46)
CKD stage at nephrology referral and factors influencing the risks of ESRD and death. (2014) (45)
Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes. (2015) (44)
Obesity, glomerular hyperfiltration, and the surface area correction. (2010) (44)
Associations between arterial stiffness, depressive symptoms and cerebral small vessel disease: cross-sectional findings from the AGES-Reykjavik Study. (2016) (43)
CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study (2009) (43)
Estimated GFR for Living Kidney Donor Evaluation (2016) (43)
Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study. (2020) (43)
Metabolomic Alterations Associated with Cause of CKD. (2017) (43)
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney. (2017) (42)
Accuracy of a GFR estimating equation over time in people with a wide range of kidney function. (2012) (42)
Living donor kidney transplantation in the United States--looking back, looking forward. (2011) (42)
Retraction. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. (2009) (41)
GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts. (2020) (41)
Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health. (2020) (40)
Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. (2007) (39)
Proteinuria in South Asian children: prevalence and determinants (2005) (38)
BP in Dialysis: Results of a Pilot Study. (2017) (38)
Ethnic differences and determinants of proteinuria among South Asian subgroups in Pakistan. (2003) (37)
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium. (2019) (37)
Cognitive dysfunction and depression in adult kidney transplant recipients: baseline findings from the FAVORIT Ancillary Cognitive Trial (FACT). (2012) (37)
Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. (2002) (37)
Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study (2022) (37)
A tripartite complex of suPAR, APOL1 risk variants and alpha(v)beta(3) integrin on podocytes mediates chronic kidney disease (37)
Serum metabolites are associated with all-cause mortality in chronic kidney disease. (2018) (36)
Effects of Race and Sex on Measured GFR: The Multi-Ethnic Study of Atherosclerosis. (2016) (36)
Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients. (2004) (36)
Fetuin-A is not associated with mortality in chronic kidney disease. (2007) (36)
GFR Evaluation in Living Kidney Donor Candidates. (2017) (36)
Pro: Estimating GFR using the chronic kidney disease epidemiology collaboration (CKD-EPI) 2009 creatinine equation: the time for change is now. (2013) (35)
Effect of Angiotensin-Converting Enzyme Inhibitors on the Progression of Nondiabetic Renal Disease (1997) (34)
Comparison of glomerular filtration rate estimating equations derived from creatinine and cystatin C: validation in the Age, Gene/Environment Susceptibility-Reykjavik elderly cohort (2018) (34)
Interferon for hepatitis C virus in hemodialysis--an individual patient meta-analysis of factors associated with sustained virological response. (2009) (34)
Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins. (2005) (34)
Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition. (2009) (34)
Metabolic alkalosis due to absorption of "nonabsorbable" antacids. (1983) (33)
Level and determinants of kidney function in a South Asian population in Pakistan. (2011) (33)
Classification of Chronic Kidney Disease: A Step Forward (2011) (33)
The challenges of the next 5 years. (2007) (32)
ESRD and death after heart failure in CKD. (2015) (32)
Dialysis Membrane and Modality in Acute Renal Failure: Understanding Discordant Meta‐Analyses (2003) (32)
A New Panel Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population. (2020) (31)
Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. (2013) (31)
Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets (2020) (31)
Chronic Kidney Disease: Common, Harmful and Treatable – World Kidney Day 2007 (2007) (31)
Strengths and limitations of estimated and measured GFR (2019) (30)
A decade after the KDOQI CKD guidelines. (2012) (30)
Estimating glomerular filtration rate using the chronic kidney disease-epidemiology collaboration creatinine equation: better risk predictions. (2012) (30)
Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study. (2019) (29)
Continuous Peritoneal Dialysis for Chronic Renal Failure (1982) (29)
High normal levels of albuminuria and risk of hypertension in Indo-Asian population. (2012) (29)
Clinical practice guidelines in nephrology--for worse or for better. (2006) (29)
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus. (2015) (29)
Low risk of liver disease after tissue transplantation from donors with HCV (1993) (28)
Biomarkers of Vitamin D Status and Risk of ESRD. (2016) (28)
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). (2016) (28)
Midlife Blood Pressure and Late-Life GFR and Albuminuria: An Elderly General Population Cohort. (2015) (28)
Constructing a database of individual clinical trials for longitudinal analysis. (2003) (28)
Serum Metabolomic Alterations Associated with Proteinuria in CKD. (2019) (27)
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). (2015) (27)
Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial. (2019) (27)
Performance of glomerular filtration rate estimating equations in a community-based sample of Blacks and Whites: the multiethnic study of atherosclerosis (2018) (27)
Staying put, but not standing still. (2012) (27)
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference (2020) (26)
Cystatin C for glomerular filtration rate estimation: coming of age. (2014) (26)
Comparing Newer GFR Estimating Equations Using Creatinine and Cystatin C to the CKD-EPI Equations in Adults. (2017) (26)
The national epidemic of chronic kidney disease (2001) (26)
Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease. (2002) (26)
Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. (2003) (25)
Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset. (2011) (25)
Role of adipose tissue in determining muscle mass in patients with chronic kidney disease. (2007) (25)
Serum β-trace protein and risk of mortality in incident hemodialysis patients. (2012) (25)
Serum Uromodulin: A Biomarker of Long-Term Kidney Allograft Failure (2018) (25)
Association of physical activity with mortality in chronic kidney disease. (2008) (25)
A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods. (2013) (25)
Long-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis. (2011) (24)
Assessing the effectiveness of therapy to prevent the progression of renal disease. (1993) (24)
Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis. (2017) (23)
Calibration of cystatin C in the National Health and Nutrition Examination Surveys (NHANES). (2013) (23)
Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group. (1999) (23)
Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial. (2016) (23)
Defining AKD: The Spectrum of AKI, AKD, and CKD (2021) (22)
Kidney Failure or Cancer (1984) (22)
GB hepatitis agent in cadaver organ donors and their recipients. (1997) (22)
Nomenclature for kidney function and disease—executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference (2020) (22)
Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial (2017) (22)
"Should the definition of CKD be changed to include age-adapted GFR criteria?": Con: the evaluation and management of CKD, not the definition, should be age-adapted. (2020) (22)
Segmental kidney volumes measured by dynamic contrast-enhanced magnetic resonance imaging and their association with CKD in older people. (2015) (21)
Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations (2021) (21)
Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort. (2017) (21)
Lifetime Risk of Stage 3-5 CKD in a Community-Based Sample in Iceland. (2015) (21)
Hepatitis C infection in cadaver organ donors: strategies to reduce transmission of infection and prevent organ waste (2004) (21)
Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD. (2018) (20)
Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland. (2016) (20)
Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). (2019) (20)
Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy. (2004) (19)
Influence of urine creatinine concentrations on the relation of albumin-creatinine ratio with cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis (MESA). (2013) (19)
Developing guidelines for chronic kidney disease: we should include all of the outcomes. (2012) (19)
Measurement and Estimation of Residual Kidney Function in Patients on Dialysis. (2018) (19)
Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. (2019) (19)
Action plan for optimizing the design of clinical trials in chronic kidney disease. (2017) (19)
Progression to Stage 4 chronic kidney disease and death, acute kidney injury and hospitalization risk: a retrospective cohort study. (2016) (19)
Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. (2016) (19)
Amoxapine‐associated acute renal failure (1983) (18)
Factors associated with serum leptin in patients with chronic kidney disease. (2004) (18)
Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease. (2022) (18)
Chronic Kidney Disease and Kidney Cancer Surgery: New Perspectives. (2020) (18)
Risk of ESRD and Mortality Associated With Change in Filtration Markers. (2017) (18)
The care of patients with chronic kidney disease (2002) (17)
Human Immunodeficiency Virus Infection in Hemodialysis Patients (1988) (17)
Which Antihypertensive Agents in Chronic Kidney Disease? (2006) (17)
Action plan for determining and monitoring the prevalence of chronic kidney disease. (2017) (17)
Improving Carboplatin Dosing Based on Estimated GFR. (2017) (16)
Aortic stiffness and change in glomerular filtration rate and albuminuria in older people (2016) (15)
Factors associated with lipoprotein(a) in chronic kidney disease. (2005) (15)
Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality. (2015) (15)
Placement of an internal jugular dialysis catheter into the superior intercostal vein. (1999) (14)
Impact of reporting estimated glomerular filtration rate: it's not just about us. (2009) (14)
Partial Nephrectomy vs. Radical Nephrectomy in Patients With Small Renal Tumors: Is There a Difference in Mortality and Cardiovascular Outcomes? (2009) (14)
Plasma Iohexol Clearance for Assessing Residual Kidney Function in Dialysis Patients. (2015) (14)
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference (2020) (14)
Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice. (2020) (14)
Aortic Stiffness and Kidney Disease in an Elderly Population (2015) (14)
Novel Filtration Markers for GFR Estimation (2017) (14)
Idiopathic Nephrotic Syndrome in a 53-Year-Old Woman (1982) (13)
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. (2020) (13)
Nephrology core curriculum. The American Society of Nephrology and the American Society of Nephrology Training Program Directors Committee. (1997) (13)
Performance of Glomerular Filtration Rate Estimating Equations Before and After Bariatric Surgery (2020) (13)
Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS. (2019) (12)
A Controlled Clinical Trial of Angiotensin-Converting Enzyme Inhibition in Type I Diabetic Nephropathy: Study Design and Patient Characteristics (1992) (12)
The Serum Metabolome Identifies Biomarkers of Dietary Acid Load in 2 Studies of Adults with Chronic Kidney Disease. (2019) (12)
The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection. (1984) (11)
Estimating Glomerular Filtration Rate Using Serum Creatinine. (2017) (11)
Acute Kidney Injury. (2018) (11)
Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression. (2018) (11)
Liver disease and HCV infection after transplantation of organs from hepatitis C antibody positive donors. (1993) (11)
Impact of pretransplantation GB virus C infection on the outcome of renal transplantation. (1997) (11)
A Prospective cross-sectional study estimated glomerular filtration rate from creatinine and cystatin C in adults with solid tumors. (2022) (11)
53 – Staging and Management of Chronic Kidney Disease (2014) (11)
Novel associations between blood metabolites and kidney function among Bogalusa Heart Study and Multi-Ethnic Study of Atherosclerosis participants (2019) (10)
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. (2017) (10)
A stable definition of chronic kidney disease improves knowledge and patient care (2013) (10)
Strategies for Assessing GFR and Albuminuria in the Living Kidney Donor Evaluation (2017) (10)
Imprecise Kidney Function Thresholds in Cancer Clinical Trials and the Potential for Harm (2018) (9)
Filtration markers in acute kidney injury. (2010) (9)
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes consensus conference* (2020) (9)
Development and Validation of Residual Kidney Function Estimating Equations in Dialysis Patients (2019) (9)
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis. (2021) (9)
Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population (2022) (9)
Comparability of Plasma Iohexol Clearance Across Population-Based Cohorts. (2019) (9)
Standardised Outcomes in Nephrology – Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy (2021) (8)
Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race. (2022) (8)
Adolescents: Evaluation, Classification, and Stratification Clinical Practice Guidelines for Chronic Kidney Disease in Children and National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (2010) (8)
Using glomerular filtration rate estimating equations: clinical and laboratory considerations. (2015) (8)
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. (2020) (8)
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference (2020) (8)
Long-Term Longitudinal Stability of Kidney Filtration Marker Measurements: Implications for Epidemiological Studies and Clinical Care. (2020) (8)
CKD and Diabetes: What Can We Learn From Their Similarities and Differences? (2016) (8)
The AGES-Reykjavik Study suggests that change in kidney measures is associated with subclinical brain pathology in older community-dwelling persons. (2018) (8)
Performance of Indexed and Nonindexed Estimated GFR. (2020) (8)
Donor specific transfusions or cyclosporine for related-donor kidney transplantation? (1989) (8)
Clinical impact of reporting estimated glomerular filtration rates. (2010) (8)
Cystatin C and muscle mass in patients with heart failure. (2020) (8)
Improving practice: reporting quality improvement activities. (2007) (8)
Antilymphocyte Antibodies, Renal Transplantation, and Meta-Analysis (1998) (8)
B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients (2017) (8)
Outcome of Peritoneal Catheter Placement in the High-Risk Patient (1984) (7)
Chronic kidney disease: common, harmful, and treatable--World Kidney Day 2007. (2007) (7)
Strategies to slow the progression of renal disease. (1994) (7)
Measurement and Estimation of Kidney Function (2019) (7)
Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes consensus conference (2020) (7)
Opinion: How Can the Cardiac Death Rate be Reduced in Dialysis Patients? (2002) (7)
Improving Glomerular Filtration Rate Estimation—Across the Age and Diversity Spectrum (2020) (7)
Estimating Kidney Failure Risk Using Electronic Medical Records. (2021) (6)
A stable definition improves knowledge and patient care (2013) (6)
An Editorial Update: What Level of Blood Pressure Control in Chronic Kidney Disease? (2005) (6)
Estimated Glomerular Filtration Rate (2007) (6)
Should the K/DOQI definition of chronic kidney disease be changed? (2003) (6)
Performance and Determinants of Serum Creatinine and Cystatin C–Based GFR Estimating Equations in South Asians (2021) (6)
Bisphosphonate utilization across the spectrum of eGFR (2020) (5)
Proteinuria among patients with chronic kidney disease: a performance measure for improving patient outcomes. (2012) (5)
Blood Pressure, CKD Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial. (2019) (5)
Focal segmental glomerulosclerosis in idiopathic membranous glomerulonephritis: a clinico-pathological and stereological study (2010) (5)
Chapter 2 – Measurement and Estimation of Kidney Function (2010) (5)
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference (2020) (5)
GFR Estimation Using a Panel of Filtration Markers in Shanghai and Beijing (2020) (5)
3 – Assessment of Glomerular Filtration Rate in Acute and Chronic Settings (2014) (5)
Predictors of GBV-C infection among patients referred for renal transplantation. (1998) (5)
Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442-1451. (2018) (5)
Waist Hip Ratio and Body Mass Index as Risk Factors for Cardiovascular Events in Chronic Kidney Disease (2009) (5)
P-285: Children in South Asia have higher body mass adjusted blood pressure levels than Caucasian children in the United States -a comparative study (2005) (5)
mTOR inhibitors and autosomal dominant polycystic kidney disease. (2011) (5)
Improving glomerular filtration rate estimation. (2019) (4)
Validation of a simple equation for glomerular filtration rate measurement based on plasma iohexol disappearance (2019) (4)
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes consensus conference. (2020) (4)
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference (2020) (4)
Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference (2020) (4)
Managing Chronic Kidney Disease in Older People--Reply. (2016) (4)
Chronic kidney disease: common, harmful and treatable—World Kidney Day 2007 (2007) (4)
Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference (2020) (4)
Use of magnesium hydroxide and low magnesium dialysate does not permit reduction of aluminum hydroxide during continuous ambulatory peritoneal dialysis. (1986) (4)
In Reply to ‘Estimated GFR for Drug Dosing: A Bedside Formula’, ‘Drug Dose Adjustments in Patients With Renal Impairment’, ‘Use of the MDRD Study Equation for Drug Dosing’, and ‘Estimated GFR vs Creatinine Clearance for Drug Dosing’ (2009) (3)
Successful Peritoneal Catheter Placement after Major Abdominal Surgery or Peritonitis (1986) (3)
National Projections for Clinical Implications of Race-Free Creatinine-Based GFR Estimating Equations (2022) (3)
Serum b -Trace Protein and Risk of Mortality in Incident Hemodialysis Patients (2012) (3)
National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Clinical Laboratories. (2021) (3)
Cardiovascular disease and subsequent kidney disease. Commentary (2007) (3)
A Rebuttal to "The CKD Classification System in the Precision Medicine Era". (2017) (3)
Dialysis facility ownership and epoetin dosing in hemodialysis patients: an overview. (2007) (3)
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial (2017) (3)
Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. (2020) (3)
Integrated Risk Assessment Versus Age-Specific GFR Thresholds for Living Donor Candidate Evaluation. (2020) (3)
Adherence to the DASH Diet and Risk of Incident Chronic Kidney Disease: the Atherosclerosis Risk in Communities (ARIC) Study (2015) (3)
Including Measures of Chronic Kidney Disease to Improve Cardiovascular Risk Prediction by SCORE2 and SCORE2-OP. (2022) (3)
A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with AKI (2015) (3)
In Reply to 'Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling'. (2016) (3)
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference (2020) (3)
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference (2020) (2)
Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference (2020) (2)
Ten Years Atop the Masthead. (2016) (2)
Performance of Serum β2-Microglobulin– and β-Trace Protein–Based Panel Markers and 2021 Creatinine- and Cystatin-Based GFR Estimating Equations in Pakistan (2022) (2)
Introducing the AJKD Atlas of Renal Pathology II (2015) (2)
Albuminuria changes and subsequent risk of end-stage renal disease and mortality (2017) (2)
Diagnostic laparotomy. (1977) (2)
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. (2020) (2)
Promoting Equity in Eligibility for Registration on the Kidney Transplantation Waiting List: Looking beyond eGFRcr. (2021) (2)
Estimating total small solute clearance in patients treated with continuous ambulatory peritoneal dialysis without urine and dialysate collection (2020) (2)
Serum Uromodulin and All-Cause Mortality in Peritoneal Dialysis Patients: A Chinese Cohort Study (2022) (2)
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference (2020) (2)
Nomenclature for kidney function and disease: executive summary from a KDIGO consensus conference (2020) (2)
Erratum: 'U' curve association of blood pressure and mortality in hemodialysis (Kidney International (1998) 54 (561-569)) (1998) (2)
Idiopathic nephrotic syndrome (2020) (2)
Effects of Body Size and Composition on Sex Differences in Measured GFR in a US Community-Based Older Cohort (MESA-Kidney). (2018) (2)
PREDICTION EQUATION FOR GLOMERULAR FILTRATION RATE. AUTHORS' REPLY (1999) (2)
eGFR and chemotherapy: will removing race create disparities? (2021) (2)
ORIGINAL INVESTIGATIONS Pathogenesis and Treatment Calibration and Random Variation of the Serum Creatinine Assay as Critical Elements of Using Equations to Estimate Glomerular Filtration Rate (2002) (2)
A Combination of Change in Albuminuria and GFR as a Surrogate End Point for Progression of CKD. (2019) (2)
Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR (2020) (2)
Is It Time to Move On? Reexamining Race in Glomerular Filtration Rate Equations. (2021) (2)
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference (2020) (2)
GFR after kidney donation: early recovery and subsequent decline. (2020) (2)
Tubular Secretion of Creatinine and Risk of Kidney Failure: The Modification of Diet in Renal Disease (MDRD) Study. (2020) (2)
Complications of Vascular Closure Devices — Not Yet Evidence Based (2016) (1)
Knowing your GFR-when is the number not (exactly) the number? (2019) (1)
Moving toward standardization of urine albumin measurements (2017) (1)
Pharmacokinetic Modeling and Simulation of Procainamide and N-Acetylprocainamide in a Patient Receiving Continuous Renal Replacement Therapy: A Novel Approach to Guide Renal Dose Adjustments (2013) (1)
Effect of first use and reuse of cuprophane membrane on interleukin 1 beta il 1 beta production by peripheral blood mononuclear cells pbmc (1991) (1)
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference (2020) (1)
In Reply to 'Newer GFR Estimating Equations Require Validation in Different Populations'. (2017) (1)
Editorial: Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes consensus conference. (2020) (1)
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. (2020) (1)
Original Investigation Serum b-Trace Protein and b2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study (2016) (1)
A87 The impact of using different albumin laboratory methods on eligibility in the HEMO study (1996) (1)
Prevalence of chronic kidney disease in a representative sample of the Polish population: results of the NATPOL 2011 survey (2016) (1)
Estimating the prevalence of chronic kidney disease while accounting for non-random testing with inverse probability weighting. (2022) (1)
New Equations for Estimating the GFR without Race. Reply. (2022) (1)
CLINICAL STUDIES Coronary Atherosclerosis Anemia as a Risk Factor for Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study (2002) (1)
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes consensus conference* (2020) (1)
Hereditary Kidney Disease: All Family Members Are Affected. (2018) (1)
Prevalence of ICD-9-CM codes for chronic kidney disease in individuals with cardiovascular disease risk factors. (2009) (1)
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. (2020) (1)
Measurement and Estimation of Residual Kidney Function in Dialysis Patients (2018) (1)
Laparoscopy: Chronic kidney disease after nephrectomy in patients with renal cortical tumours: A retrospective cohort study - Commentary (2007) (1)
In Reply to ‘CKD in the Elderly’ (2008) (1)
Arterial stiffness is associated with depressive symptoms and this association is partly mediated by cerebral small vessel disease: The AGES-Reykjavik study (2014) (1)
Frontiers in Internal Medicine. (1997) (1)
Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline. (2018) (1)
Serum metabolomic signatures of plant-based diets and incident chronic kidney disease (2022) (1)
Chronic kidney disease: classification, risk factors, and natural history (2009) (1)
A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease. (2021) (1)
Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625–637 (2018) (1)
Epidemiology and Prevention Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Statement From the American Heart Association Councils on Kidney in Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A (2011) (1)
CKD and Risk of Incident Hospitalization With Clostridioides Difficile Infection: Findings From the Atherosclerosis Risk in Communities (ARIC) Study (2021) (0)
CKD in the elderly. Authors' reply (2008) (0)
P09 A pilot study for feasibility of long-term patient follow-up after the end of a clinical trial (1996) (0)
A Prospective Cross-Sectional Study on the Performance of the 2021 CKD-EPI Equations Without Race in a Multiracial Population of Adults With Solid Tumors in Brazil. (2023) (0)
Supplementary Material for: Aortic Stiffness and Kidney Disease in an Elderly Population (2015) (0)
Long-term medical risks to the living (2015) (0)
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease : Data from the TREAT trial (2018) (0)
β2-Microglobulin and β-Trace Protein in Patients Undergoing Bariatric Surgery: Non-GFR Determinants and Panel-estimated GFR Performance (2021) (0)
P-400: Baseline characteristics of ALLHAT participants with impaired renal function: association with coexistent cardiovascular disease (2002) (0)
Target blood pressure and kidney disease [2] (multiple letters) (2005) (0)
Abstract 14782: Impact of Black Race on Progression to End-Stage Renal Disease Despite Similar Outcomes for Cardiovascular Morbidity and Mortality: The TREAT Study (2013) (0)
Angiotensin-Converting Enzyme Inhibitors in Nondiabetic Renal Disease (1998) (0)
IN THE LITERATURE Filtration Markers in Acute Kidney Injury (2010) (0)
Abstract MP13: Serum Metabolomic Signatures Of Plant-based Diets And Incident Chronic Kidney Disease (2022) (0)
Original Investigation Effects of Race and Sex on Measured GFR: The Multi-Ethnic Study of Atherosclerosis (2016) (0)
In Reply to 'Multiple-Biomarker Panel Estimated GFR Is Not Optimal or Cost-Effective' and 'Comparing Multiple-Biomarker Panels for Estimating GFR With Estimating Equations Without a Coefficient Distinguishing Black Individuals From Persons of Other Groups'. (2021) (0)
Original Investigation GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials (2014) (0)
1099-89 The incidence of clinically unrecognized myocardial infarction in patients with type 2 diabetes, hypertension, and nephropathy (2004) (0)
Estimated glomerular filtration rate. Authors' reply (2007) (0)
EFFECTS OF DIETARY PROTEIN ON RENAL DISEASE. AUTHORS'REPLY (1997) (0)
A Dynamic Predictive Model for the Progression of Chronic Kidney Disease to Kidney Failure (2016) (0)
The Improving Prognosis After Kidney Transplantation: New Strategies to Overcome Immunologic Rejection (1985) (0)
Accuracy of GFR Estimating Equations in Patients with Discordances Between Creatinine and Cystatin C-Based Estimations. (2023) (0)
Abstract MP28: Filtration Markers, Cardiovascular Disease and All-cause Mortality in Kidney Transplant Recipients: The FAVORIT Trial (2016) (0)
P85 Use of physician investigators for outcome review in the hemodialysis (HEMO) study (1997) (0)
15. Fan F, Yuan Z, Qin X et al. Optimal systolic blood pressure levels for primary prevention of stroke in general hypertensive adults: findings from the CSPPT (2018) (0)
Abstract P213: Serum Metabolomic Profile of Dietary Acid Load in Two Chronic Kidney Disease Studies (2019) (0)
094: Framingham Risk Score Predicts Prevalent Chronic Kidney Disease in Women (2005) (0)
Social Determinants of Health and Their Impact on the Black Race Coefficient in Serum Creatinine–Based Estimation of GFR (2023) (0)
A Novel Creatinine Muscle Index Based on Creatinine Filtration: Associations with Frailty and Mortality (2023) (0)
University of Groningen A New Panel-Estimated GFR, Including beta(2)-Microglobulin and beta-Trace Protein and Not Including Race, Developed in a Diverse Population CKD-EPI GFR Collaborators; Inker, (2021) (0)
List of Contributors (2019) (0)
P105 Maintenance of adherence to a dietary intervention 9 months after completion of a clinical trial (1995) (0)
Use of eGFR in Older Adults with Kidney Disease. Reply. (2022) (0)
Abstract 022: Cystatin C Strengthens the Association of Kidney Function with Mortality and End-Stage Renal Disease (2013) (0)
Prediction Equation for Glomerular Filtration Rate (1999) (0)
Worldwide cardiovascular and ESRD outcomes attributable to reduced GFR Running Title: Reduced GFR-attributed health loss (2018) (0)
B-type natriuretic peptide and cardiac troponin I are associated withadverse outcomes in stable kidney transplant recipients (2016) (0)
Fibroblast growth factor 23 and CKD prognosis. (2012) (0)
CARDIAC TROPONIN I AND B-TYPE NATRIURETIC PEPTIDE PREDICT CLINICAL OUTCOMES IN STABLE RENAL TRANSPLANT RECIPIENTS (2014) (0)
Estimating Glomerular Filtration Rate in African American Individuals-Reply. (2020) (0)
Ethical considerations in the design of a randomized clinical trial of nutritional therapy for chronic renal disease (1988) (0)
MDRD Study data suggest benefits of low-protein diets (1995) (0)
Research: Basic and Clinical (2000) (0)
Cystatin C Strengthens the Association of Kidney Function with Mortality and End-Stage Renal Disease (2013) (0)
151: Uric Acid and Long-Term Outcomes in Chronic Kidney Disease (2008) (0)
Abstract P172: Prevalence of Reduced Estimated Glomerular Filtration and Albuminuria In Clinically Relevant Subgroups in a Representative Elderly Population in Iceland (2015) (0)
to reduced GFR (2017) (0)
In Reply to 'The Importance of Considering Metabolism When Indexing the GFR' (2010) (0)
P25 Representativeness of clinical trial participants: The hemodialysis study (1996) (0)
Cardiovascular disease in chronic kidney disease : Emphasis on left ventricular hypertrophy (2001) (0)
AJKD at 40: The Boston Era-Years 25-35 (2007-2016). (2021) (0)
The laboratory diagnostics of chronic kidney diseases Novel filtration markers for GFR estimation (2017) (0)
The CKD-EPI Equation and MDRD Study Equation Find Similar Prevalence of Chronic Kidney Disease in Asian Populations (0)
Evaluation of Glomerular Filtration Rate, Albuminuria and Hematuria in Living Donor Candidates (2021) (0)
DECLINE IN KIDNEY FUNCTION AND SUBCLINICAL BRAIN PATHOLOGIES (2016) (0)
Waist-to-Hip Ratio , Body Mass Index , and Subsequent Kidney Disea and Death (2008) (0)
Original Investigation A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury (2015) (0)
Prediction equation for glomerular filtration rate [1] (multiple letters) (1999) (0)
The authors reply. (2022) (0)
In Reply to ‘What Dominates Living Donor Kidney Transplantation: Altruism or Loss of Dignity?’ (2012) (0)
High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention From the American Heart Association Councils on Kidney in Cardiovascular Disease, Kidney Disease as a Risk Factor for Development of Cardiovascular Disease : A Statement (2013) (0)
Abstract MP07: Soluble Urokinase-type Plasminogen Activator Receptor is associated with progression of hypertension-attributed chronic kidney disease in African Americans (2018) (0)
In memoriam: John T. Harrington (2018) (0)
Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease. (2014) (0)
1 C-Reactive Protein and Risk of End-Stage Renal Disease – Results from TREAT ( Trial to Reduce cardiovascular Events with Aranesp Therapy ) (2016) (0)
Level and Its Past Trajectory for Risk of Progression to End-Stage Renal Disease : Meta-Analysis of 22 Cohorts in the CKD Prognosis Consortium (2014) (0)
K/doqi Tm Disclaimer K/doqi Advisory Board Members K/doqi Tm Nutrition Work Group Membership Adult Work Group Members Pediatric Work Group Members Nkf-doqi Advisory Council* Nkf-doqi Steering Committee* Acronyms and Abbreviations List Abbreviation Term A1-ag A1-acid Glycoprotein Abw Ef Adjusted Edem (0)
Effects of Dietary Protein on Renal Disease (1997) (0)
New Strategies to Overcome Immunologic Rejection (2016) (0)
Response to Letter Regarding Article, “Relationship Between Homocysteine and Mortality in Chronic Kidney Disease” (2006) (0)
Sex Disparities in the Quality of Care for CKD. (2022) (0)
Food Records Vs Urine Urea Nitrogen in Assessing Adherence to a Low- Protein Diet in Early Stage Chronic Renal Insufficiency. (1997) (0)
Bardoxolone methyl, chronic kidney disease, and type 2 diabetes. (2011) (0)
Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials : A Meta-Analysis of Treatment Effects of Randomized Controlled Trials (2019) (0)
Summary and Comment: Frequency of Sit‐Down Patient Care Rounds, Attainment of Clinical Performance Targets, Hospitalization, and Mortality in Hemodialysis Patients (2005) (0)
FC078: Impact of Removing Race from the CKD-EPI Equation: Analysis of 1.6 Million Swedish Adults (2022) (0)
Kidney Transplantation in Lupus Nephritis: Can We Do Even Better? (2019) (0)
103-S: A Simple Prediction Rule for Chronic Kidney Disease in Healthy Men (2005) (0)
In Reply to 'How Valid Are GFR Estimation Results From the CKD-EPI Databases?' (2017) (0)
In reply to 'Creatinine-based GFR estimating equations in kidney transplant recipients' and 'Assessing kidney function in transplant recipients: time to work together and address the most relevant questions'. (2014) (0)
Target Blood Pressure and Kidney Disease (2005) (0)
end-organ damage for function of the peripheral vasculature: implications Effects of central arterial aging on the structure and (2015) (0)
New GFR-estimating equations for children and young adults in North America and Europe. (2021) (0)
Putting together a database of individual clinical trials for longitudinal analysis (2001) (0)
Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland. (2015) (0)

This paper list is powered by the following services:

Other Resources About Andrew S. Levey

en.wikipedia.org

What Schools Are Affiliated With Andrew S. Levey?

Andrew S. Levey is affiliated with the following schools: